Annual Operating Profit
-$17.52 M
-$5.23 M-42.56%
December 31, 2023
Summary
- As of February 27, 2025, OPRX annual operating income is -$17.52 million, with the most recent change of -$5.23 million (-42.56%) on December 31, 2023.
- During the last 3 years, OPRX annual operating profit has fallen by -$15.39 million (-720.58%).
- OPRX annual operating profit is now -2324.14% below its all-time high of $787.80 thousand, reached on December 31, 2018.
Performance
OPRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$1.07 M
+$2.68 M+71.38%
September 30, 2024
Summary
- As of February 27, 2025, OPRX quarterly operating income is -$1.07 million, with the most recent change of +$2.68 million (+71.38%) on September 30, 2024.
- Over the past year, OPRX quarterly operating profit has increased by +$2.48 million (+69.80%).
- OPRX quarterly operating profit is now -179.10% below its all-time high of $1.36 million, reached on December 31, 2020.
Performance
OPRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$11.87 M
+$2.48 M+17.28%
September 30, 2024
Summary
- As of February 27, 2025, OPRX TTM operating income is -$11.87 million, with the most recent change of +$2.48 million (+17.28%) on September 30, 2024.
- Over the past year, OPRX TTM operating profit has increased by +$4.45 million (+27.28%).
- OPRX TTM operating profit is now -1001.24% below its all-time high of $1.32 million, reached on June 30, 2019.
Performance
OPRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
OPRX Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -42.6% | +69.8% | +27.3% |
3 y3 years | -720.6% | -272.8% | -3388.5% |
5 y5 years | -2324.1% | +29.4% | -310.3% |
OPRX Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -4952.3% | at low | -272.8% | +84.8% | -3388.5% | +32.1% |
5 y | 5-year | -4952.3% | at low | -179.1% | +84.8% | -1183.0% | +32.1% |
alltime | all time | -2324.1% | at low | -179.1% | +84.8% | -1001.2% | +32.1% |
OptimizeRx Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$1.07 M(-71.4%) | -$11.87 M(-17.3%) |
Jun 2024 | - | -$3.75 M(-25.5%) | -$14.35 M(-7.1%) |
Mar 2024 | - | -$5.03 M(+148.5%) | -$15.45 M(-11.6%) |
Dec 2023 | -$17.52 M(+42.6%) | -$2.02 M(-43.0%) | -$17.49 M(+7.1%) |
Sep 2023 | - | -$3.55 M(-26.7%) | -$16.33 M(-1.2%) |
Jun 2023 | - | -$4.85 M(-31.3%) | -$16.53 M(+6.0%) |
Mar 2023 | - | -$7.06 M(+717.2%) | -$15.59 M(+26.9%) |
Dec 2022 | -$12.29 M(-3503.7%) | -$864.30 K(-77.0%) | -$12.29 M(+13.7%) |
Sep 2022 | - | -$3.76 M(-3.9%) | -$10.81 M(+54.1%) |
Jun 2022 | - | -$3.91 M(+3.9%) | -$7.01 M(+153.8%) |
Mar 2022 | - | -$3.76 M(-705.6%) | -$2.76 M(-864.8%) |
Dec 2021 | $361.10 K(-116.9%) | $621.10 K(+1525.9%) | $361.10 K(-67.1%) |
Sep 2021 | - | $38.20 K(-88.8%) | $1.10 M(+24.4%) |
Jun 2021 | - | $340.10 K(-153.3%) | $881.60 K(-271.4%) |
Mar 2021 | - | -$638.30 K(-147.1%) | -$514.30 K(-75.9%) |
Dec 2020 | -$2.14 M(-26.2%) | $1.36 M(-867.7%) | -$2.14 M(-57.4%) |
Sep 2020 | - | -$176.70 K(-83.3%) | -$5.01 M(-26.5%) |
Jun 2020 | - | -$1.06 M(-53.3%) | -$6.82 M(+29.1%) |
Mar 2020 | - | -$2.26 M(+48.8%) | -$5.29 M(+82.6%) |
Dec 2019 | -$2.89 M(-467.3%) | -$1.52 M(-23.6%) | -$2.89 M(+208.4%) |
Sep 2019 | - | -$1.99 M(-514.0%) | -$938.50 K(-171.2%) |
Jun 2019 | - | $480.00 K(+263.1%) | $1.32 M(+18.6%) |
Mar 2019 | - | $132.20 K(-69.7%) | $1.11 M(+41.1%) |
Dec 2018 | $787.80 K(-137.0%) | $436.60 K(+62.4%) | $787.80 K(+604.0%) |
Sep 2018 | - | $268.80 K(-1.8%) | $111.90 K(-114.2%) |
Jun 2018 | - | $273.60 K(-243.1%) | -$786.60 K(-45.0%) |
Mar 2018 | - | -$191.20 K(-20.1%) | -$1.43 M(-32.8%) |
Dec 2017 | -$2.13 M(+39.1%) | -$239.30 K(-62.0%) | -$2.13 M(-10.1%) |
Sep 2017 | - | -$629.70 K(+69.9%) | -$2.37 M(+19.1%) |
Jun 2017 | - | -$370.60 K(-58.4%) | -$1.99 M(-3.5%) |
Mar 2017 | - | -$890.40 K(+86.3%) | -$2.06 M(+34.5%) |
Dec 2016 | -$1.53 M | -$477.90 K(+91.8%) | -$1.53 M(+4.2%) |
Sep 2016 | - | -$249.20 K(-43.7%) | -$1.47 M(+29.7%) |
Jun 2016 | - | -$442.50 K(+22.3%) | -$1.13 M(+33.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2016 | - | -$361.80 K(-13.0%) | -$847.60 K(+41.9%) |
Dec 2015 | -$597.40 K(-4.6%) | -$415.90 K(-574.8%) | -$597.30 K(-1314.0%) |
Sep 2015 | - | $87.60 K(-155.6%) | $49.20 K(-114.8%) |
Jun 2015 | - | -$157.50 K(+41.3%) | -$333.20 K(-11.3%) |
Mar 2015 | - | -$111.50 K(-148.4%) | -$375.60 K(-40.0%) |
Dec 2014 | -$626.30 K(+134.1%) | $230.60 K(-178.2%) | -$626.30 K(-14.7%) |
Sep 2014 | - | -$294.80 K(+47.5%) | -$734.50 K(+26.4%) |
Jun 2014 | - | -$199.90 K(-44.8%) | -$581.30 K(+106.4%) |
Mar 2014 | - | -$362.20 K(-395.9%) | -$281.60 K(+95.7%) |
Dec 2013 | -$267.50 K(-41.2%) | $122.40 K(-186.4%) | -$143.90 K(-39.5%) |
Sep 2013 | - | -$141.60 K(-241.9%) | -$237.90 K(+17.5%) |
Jun 2013 | - | $99.80 K(-144.5%) | -$202.50 K(-46.5%) |
Mar 2013 | - | -$224.50 K(-890.5%) | -$378.50 K(-16.8%) |
Dec 2012 | -$454.90 K(-68.7%) | $28.40 K(-126.7%) | -$454.90 K(-47.5%) |
Sep 2012 | - | -$106.20 K(+39.4%) | -$867.20 K(-25.9%) |
Jun 2012 | - | -$76.20 K(-74.7%) | -$1.17 M(-22.7%) |
Mar 2012 | - | -$300.90 K(-21.6%) | -$1.51 M(+4.2%) |
Dec 2011 | -$1.45 M(-21.2%) | -$383.90 K(-6.2%) | -$1.45 M(+14.1%) |
Sep 2011 | - | -$409.20 K(-2.7%) | -$1.27 M(-7.0%) |
Jun 2011 | - | -$420.50 K(+74.9%) | -$1.37 M(-24.9%) |
Mar 2011 | - | -$240.40 K(+18.0%) | -$1.82 M(-1.2%) |
Dec 2010 | -$1.85 M(-59.7%) | -$203.80 K(-59.7%) | -$1.85 M(-53.5%) |
Sep 2010 | - | -$505.20 K(-42.3%) | -$3.97 M(-2.8%) |
Jun 2010 | - | -$875.40 K(+234.4%) | -$4.09 M(+14.7%) |
Mar 2010 | - | -$261.80 K(-88.8%) | -$3.56 M(-23.8%) |
Dec 2009 | -$4.59 M(+204.1%) | -$2.33 M(+276.8%) | -$4.68 M(+42.4%) |
Sep 2009 | - | -$619.00 K(+75.9%) | -$3.28 M(+16.2%) |
Jun 2009 | - | -$352.00 K(-74.4%) | -$2.83 M(+5.6%) |
Mar 2009 | - | -$1.38 M(+46.6%) | -$2.68 M(+76.4%) |
Dec 2008 | -$1.51 M(+323.7%) | -$938.10 K(+481.2%) | -$1.52 M(+162.0%) |
Sep 2008 | - | -$161.40 K(-20.2%) | -$579.20 K(+38.6%) |
Jun 2008 | - | -$202.20 K(-6.2%) | -$417.80 K(+93.8%) |
Mar 2008 | - | -$215.60 K | -$215.60 K |
Dec 2007 | -$355.90 K | - | - |
FAQ
- What is OptimizeRx annual operating income?
- What is the all time high annual operating profit for OptimizeRx?
- What is OptimizeRx annual operating profit year-on-year change?
- What is OptimizeRx quarterly operating income?
- What is the all time high quarterly operating profit for OptimizeRx?
- What is OptimizeRx quarterly operating profit year-on-year change?
- What is OptimizeRx TTM operating income?
- What is the all time high TTM operating profit for OptimizeRx?
- What is OptimizeRx TTM operating profit year-on-year change?
What is OptimizeRx annual operating income?
The current annual operating profit of OPRX is -$17.52 M
What is the all time high annual operating profit for OptimizeRx?
OptimizeRx all-time high annual operating income is $787.80 K
What is OptimizeRx annual operating profit year-on-year change?
Over the past year, OPRX annual operating income has changed by -$5.23 M (-42.56%)
What is OptimizeRx quarterly operating income?
The current quarterly operating profit of OPRX is -$1.07 M
What is the all time high quarterly operating profit for OptimizeRx?
OptimizeRx all-time high quarterly operating income is $1.36 M
What is OptimizeRx quarterly operating profit year-on-year change?
Over the past year, OPRX quarterly operating income has changed by +$2.48 M (+69.80%)
What is OptimizeRx TTM operating income?
The current TTM operating profit of OPRX is -$11.87 M
What is the all time high TTM operating profit for OptimizeRx?
OptimizeRx all-time high TTM operating income is $1.32 M
What is OptimizeRx TTM operating profit year-on-year change?
Over the past year, OPRX TTM operating income has changed by +$4.45 M (+27.28%)